⚞(⦾.⦾)⚟ | $LABU $LABD | MA + RSI | v0.5
Today’s Change (Aug 7, 2026)
—
A symphony is an automated trading strategy — Learn more about symphonies here
About
A daily biotech trend rider using 3x bull/bear ETFs. Trades LABU when short-term biotech trend is up, may flip to LABD on overbought wobble, and holds QQQ when no biotech uptrend. Uses very short moving averages and a short RSI. Very high risk.
It trades the biotech sector using 3x ETFs: LABU (goes up when biotech rises) and LABD (goes up when biotech falls). If biotech’s short-term trend (2-day avg) isn’t above its 10-day avg, it parks in QQQ (big-tech). In uptrends it mostly holds LABU. If price gets very “hot” (RSI, a 0–100 heat gauge, is high), it uses tiny trend checks (2 vs 3-day averages) to flip briefly to LABD or back to LABU. Rebalances daily.
Out-of-sample annualized return ~44% vs ~18% for the S&P, driven by a biotech 3x trend system (LABU/LABD) with timely hedges. Higher risk, but potential for outsized biotech gains; max drawdown ~48% vs ~19% for the S&P.
1M
3M
6M
YTD
1Y
3Y
Max
Performance
Compared to selected benchmarks
| Alpha | Beta | R2 | R | |
|---|---|---|---|---|
| -0.08 | 1.56 | 0.18 | 0.42 |
Performance Metrics
| Cumulative Return | Annualized Return | Trailing 1M Return | Trailing 3M Return | Sharpe Ratio | |
|---|---|---|---|---|---|
| 351.96% | 14.79% | 2.3% | 5% | 0.86 | |
| -48.27% | -5.85% | -7.53% | 16.27% | 0.24 |
Initial Investment
$10,000.00
Final Value
$5,173.33Regulatory Fees
$101.12
Total Slippage
$857.26
Invest in this strategy
OOS Start Date
Oct 17, 2024
Trading Setting
Daily
Type
Stocks
Category
Trend-following, biotech, leveraged etfs, momentum, rsi, moving averages, tactical allocation, long/short, daily rebalance